Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Goldstein

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Nature Reviews. Clinical Oncology|July 28, 2025
Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timingAvi Petroff, Ian F Tannock, Daniel A Goldstein
Parkinsonism & Related Disorders|June 16, 2018
"Reversible Parkinsonism" following glyphosate exposureDaniel A Goldstein, S Eliza Dunn, Katherine Karberg
Oncology (Williston Park, N.Y.)|March 19, 2015
Costs and effectiveness of genomic testing in the management of colorectal cancerDaniel A Goldstein, Walid L Shaib, Christopher R Flowers
JAMA Oncology|June 21, 2019
Interventional Pharmacoeconomics-A New Discipline for a Cost-Constrained EnvironmentMark J Ratain, Daniel A Goldstein, Allen S Lichter
The Lancet. Oncology|October 30, 2025
Subcutaneous immunotherapy-a wolf in sheep's clothing?Roni Levin, Amol Akhade, Manju Sengar, et al.
JAMA Oncology|March 12, 2016
Perspectives in Oncology Drug Pricing-ReplyDaniel A Goldstein, David H Howard, Christopher R Flowers
Expert Review of Pharmacoeconomics & Outcomes Research|November 10, 2016
Economics of ramucirumab for metastatic colorectal cancerSimon B Zeichner, Christine G Kohn, Daniel A Goldstein
JAMA Oncology|May 28, 2020
Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19Daniel A Goldstein, Mark J Ratain, Leonard B Saltz
Cost Effectiveness and Resource Allocation : C/E|March 15, 2019
Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage <i>HER2</i>-positive breast cancerNoga Gershon, Yakir Berchenko, Peter S Hall, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 15, 2011
Comment: Aris and Leblanc "Maternal and fetal exposure to pesticides associated to genetically modified foods in Eastern Townships of Quebec, Canada"Daniel A Goldstein, Samuel Dubelman, David Grothaus, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Nature Reviews. Clinical Oncology|July 28, 2025
Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timingAvi Petroff, Ian F Tannock, Daniel A Goldstein
Parkinsonism & Related Disorders|June 16, 2018
"Reversible Parkinsonism" following glyphosate exposureDaniel A Goldstein, S Eliza Dunn, Katherine Karberg
Oncology (Williston Park, N.Y.)|March 19, 2015
Costs and effectiveness of genomic testing in the management of colorectal cancerDaniel A Goldstein, Walid L Shaib, Christopher R Flowers
JAMA Oncology|June 21, 2019
Interventional Pharmacoeconomics-A New Discipline for a Cost-Constrained EnvironmentMark J Ratain, Daniel A Goldstein, Allen S Lichter
The Lancet. Oncology|October 30, 2025
Subcutaneous immunotherapy-a wolf in sheep's clothing?Roni Levin, Amol Akhade, Manju Sengar, et al.
JAMA Oncology|March 12, 2016
Perspectives in Oncology Drug Pricing-ReplyDaniel A Goldstein, David H Howard, Christopher R Flowers
Expert Review of Pharmacoeconomics & Outcomes Research|November 10, 2016
Economics of ramucirumab for metastatic colorectal cancerSimon B Zeichner, Christine G Kohn, Daniel A Goldstein
JAMA Oncology|May 28, 2020
Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19Daniel A Goldstein, Mark J Ratain, Leonard B Saltz
Cost Effectiveness and Resource Allocation : C/E|March 15, 2019
Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage <i>HER2</i>-positive breast cancerNoga Gershon, Yakir Berchenko, Peter S Hall, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 15, 2011
Comment: Aris and Leblanc "Maternal and fetal exposure to pesticides associated to genetically modified foods in Eastern Townships of Quebec, Canada"Daniel A Goldstein, Samuel Dubelman, David Grothaus, et al.
Pageof 14